HCW Biologics Inc Sustainability Reports
HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company leverages its proprietary TOBI platform to engineer multi-functional fusion protein molecules and complexes targeting oncology and autoimmune markets.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5299008ZJ4RXXTN04Z97
3 reports from 2021 to 2024
